Join the Oncology Voice Network. Join for Free
The 3 “Knows” of Effective Scientific Communication
scientific communication Medical Science Liaisons audience analysis storytelling techniques Key Opinion Leaders

The 3 “Knows” of Effective Scientific Communication


Share This Article


Summary

In this episode, Tom Caravela is joined by guest Linda Traylor who discusses the 3 "knows" of scientific communication for Medical Science Liaisons (MSLs). She shares the framework of scientific communication and its impact on the value and expectations of medical affairs. Self-awareness and audience analysis are emphasized to enhance engagement. The episode highlights common mistakes in audience interaction and data contextualization, offering professional development tips. It also covers storytelling techniques and strategies for effective meetings with Key Opinion Leaders (KOLs). The episode concludes with a book recommendation, acknowledgment of guest expertise, and additional resources.

Key Points

  • Understanding and adapting to the evolving landscape of scientific communication, including the use of AI tools and digital platforms, is crucial for medical affairs teams.
  • MSLs should focus on the three essential aspects of effective communication: knowing themselves, knowing their audience, and knowing their subject, to maximize engagements with healthcare professionals.
  • Building self-awareness through tools like personality assessments, aligning communication styles with the audience to eliminate distractions, and contextualizing data within the patient, HCP, and product journeys are key strategies for successful scientific exchanges.

Click for Source
scientific communication, Medical Science Liaisons, audience analysis, storytelling techniques, Key Opinion Leaders

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Article
Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO

Expert perspectives live from ASCO® 2025

Explore OVN